Macrocyclization of a potent PACE4 inhibitor: benefits and limitations

Teresa Łepek , Anna Kwiatkowska , Frédéric Couture , Kévin Ly , Roxane Desjardins , Yves Dory , Adam Prahl , Robert Day

Abstract

n/a
Author Teresa Łepek (FCh / DOCh / LChB)
Teresa Łepek,,
- Laboratory of Chemistry of Biopolymers
, Anna Kwiatkowska
Anna Kwiatkowska,,
-
, Frédéric Couture
Frédéric Couture,,
-
, Kévin Ly
Kévin Ly,,
-
, Roxane Desjardins
Roxane Desjardins,,
-
, Yves Dory
Yves Dory,,
-
, Adam Prahl (FCh / DOCh / LChB)
Adam Prahl,,
- Laboratory of Chemistry of Biopolymers
, Robert Day
Robert Day,,
-
Journal seriesEuropean Journal of Cell Biology, ISSN 0171-9335, (A 25 pkt)
Issue year2017
Vol96
No5
Pages476-485
Publication size in sheets0.5
Keywords in Englishproprotein convertases, prostate cancer, PACE4 inhibitors, cyclization, peptides stability
DOIDOI:10.1016/j.ejcb.2017.04.001
URL https://doi.org/10.1016/j.ejcb.2017.04.001
Languageen angielski
Score (nominal)25
ScoreMinisterial score = 25.0, 26-01-2018, ArticleFromJournal
Ministerial score (2013-2016) = 25.0, 26-01-2018, ArticleFromJournal
Publication indicators WoS Impact Factor: 2016 = 3.712 (2) - 2016=3.753 (5)
Citation count*
Cite
Share Share

Get link to the record


* presented citation count is obtained through Internet information analysis and it is close to the number calculated by the Publish or Perish system.
Back